Latest News | Natco Pharma Launches First Generic Version of Pomalyst Capsules in Australia

New Delhi, Nov 9 (PTI) Natco Pharma on Wednesday announced the launch of the first generic version of Pomalyst capsules in the Australian market.

The capsules have been launched in strengths of 1,2,3 and 4 mg.

Also Read | Manchester City vs Chelsea, Carabao Cup 2022-23 Free Live Streaming Online & Match Time in India: How To Watch Carabao Cup Match Live Telecast on TV & Football Score Updates in IST?.

Pomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.

The product was launched by Natco's commercial partner Juno Pharmaceuticals Pty Ltd.

Also Read | Arsenal vs Brighton and Hove Albion, Carabao Cup 2022-23 Free Live Streaming Online & Match Time in India: How To Watch Carabao Cup Match Live Telecast on TV & Football Score Updates in IST?.

"Pomalyst registered sales of USD 35.6 million in the Australian market for the year ending 31 March 2022 as per industry sales data," Natco Pharma said in a statement.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)